---
$id: https://graph.org.ai/products/commodity/51161567
$type: Product
source: UNSPSC
code: "51161567"
title: "Eprozinol dihydrochloride"
class: "51161500"
classTitle: "Antiasthmatic drugs"
family: "51160000"
familyTitle: "Drugs affecting the respiratory tract"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Eprozinol dihydrochloride

**UNSPSC Code**: 51161567
**Class**: [Antiasthmatic drugs](Antiasthmatic drugs.mdx)
**Family**: [Drugs affecting the respiratory tract](../Drugs affecting the respiratory tract.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a histamine-1 receptor antagonist with the molecular formula C22H30N2O2.2ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X9AMI360PI, chemically known as 1-piperazinepropanol, 4-(2-methoxy-2-phenylethyl)-.alpha.-phenyl-, hydrochloride (1:2), but more generally known as eprozinol dihydrochloride, which bears US NIH Compound Identifier 161574. European Medicines Agency schedules eprozinol dihydrochloride or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06589MIG. Most nations, for tariff purposes, schedule eprozinol dihydrochloride under HS 29335995. SMILES: COC(CN1CCN(CC1)CCC(C2CCCCC2)O)C3CCCCC3.CL.CL.

